| Michelle Dionne, | |
|
109 Ponemah Rd Ste 9, Amherst, NH 03031-2834 | |
| (603) 249-5771 | |
| Not Available |
| Full Name | Michelle Dionne |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Infusion Therapy |
| Location | 109 Ponemah Rd Ste 9, Amherst, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396117958 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WI0500X | Registered Nurse - Infusion Therapy | 053868-21 (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michelle Dionne, 109 Ponemah Rd Ste 9, Amherst, NH 03031-2834 Ph: (603) 249-5771 | Michelle Dionne, 109 Ponemah Rd Ste 9, Amherst, NH 03031-2834 Ph: (603) 249-5771 |
News Archive
Studies in which monkeys were asked to manipulate computer cursors for fruit juice rewards have revealed that the brain's "executive" center plans behaviors not by specifying movements required for given actions, but rather the events that will result from those actions.
Access to some antiretroviral drugs is increasing in Thailand because of the country's decision to issue compulsory licenses for certain medications, Winai Sawasdiworn, deputy secretary-general of the National Health Security Office, said recently, the Bangkok Post reports (Apiradee, Bangkok Post, 5/8).
The insurer's second quarter earnings increased 17 percent as it reaped enrollment and revenue gains from its acquisition of the managed health care company Coventry Health Care Inc.
Cincinnati-based RTM Consulting, the leading provider of Resource Management Solutions for consulting and professional services organizations in the technology sector, announced today that The TriZetto Group, Inc. has selected RTM Consulting's Skills Development and Training Services to integrate into its internal Associate Level Professional Skills Certification Program.
The Tuberous Sclerosis Alliance (TS Alliance) today announced the first drug approved for a tuberous sclerosis complex (TSC) indication by the Federal Drug Administration (FDA). This drug, manufactured by Novartis Oncology, is called Afinitor and will be used to treat subependymal giant cell astrocytomas (SEGAs) in individuals with TSC.
› Verified 6 days ago
Christina Emmanuel Connors, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 10 Deerwood Dr, Amherst, NH 03031 Phone: 908-868-1637 | |
Farrah Sheehan, RN, IBCLC Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 8 Fox Run Rd, Amherst, NH 03031 Phone: 603-540-2734 | |
Loretta Theresia Macey, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 109 Ponemah Rd, Suite 9, Amherst, NH 03031 Phone: 603-249-5771 | |
Mark Hutchings, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 109 Ponemah Rd Ste 9, Amherst, NH 03031 Phone: 603-249-5771 |